Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2025-12-25 @ 9:45 PM
NCT ID: NCT00225251
Description: patients were assessed for side effects over the course of the efficacy study
Frequency Threshold: 5
Time Frame: 10 weeks
Study: NCT00225251
Study Brief: Wellbutrin XL for Dysthymic Disorder
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Bupropion XL Treatment with active medication (bupropion XL) dose ranging from 150 to 450 mg/day bupropion XL: Antidepressant medication None None 0 11 6 11 View
Placebo Placebo comparator, matching appearance with active medication, taken from 1 to 3 tablets per day None None 0 7 3 7 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
dry mouth NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
dizziness NON_SYSTEMATIC_ASSESSMENT Nervous system disorders None View
insomnia NON_SYSTEMATIC_ASSESSMENT Nervous system disorders None View
headache NON_SYSTEMATIC_ASSESSMENT Nervous system disorders None View